{"date":"2026-11-02","entries":[{"entry_hash":"17bc6dec1a00861d062ec88d46d1ee825541a6266a2c3bb12e2c29825957ceda","family":"Realwirtschaft (Halbleiter)","held":0.0,"id":"07d8d8b7faa2","n_significant":20.0,"signal":"P6D_WSTS_BILLINGS_YOY","type":"signal","verdict":"auffällig instabil (unter Placebo-5 %)"},{"beat_benchmark":0.432,"entry_hash":"27967f4d78665ac71a049b8d40e729313740fb9a42afae9bf01e03d9a208c33a","id":"08ea9c259a95","median_sharpe_diff":-0.021,"scope":{"anlageklasse":"alle","mechanismus":"behavioural"},"tests":88,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"entry_hash":"03b4d4dcea97269c4e9fec5ec58a33226ed471acedbd1d2fb1e5b815fb461900","family":"Kalender","held":0.782608695652174,"id":"0b1596b37471","n_significant":23.0,"signal":"CAL_TOM","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"d956c345b0d062c20066d8fa200ec77967bcd63392aadd126a878213096893e9","family":"Geldflüsse (ETF)","held":0.9795918367346939,"id":"0c5fa5269ad9","n_significant":98.0,"signal":"P6D_ETF_FLOW20_XLK","type":"signal","verdict":"auffällig stabil (über Placebo-95 %)"},{"beat_benchmark":0.423,"entry_hash":"a43aaf8aa7c4f48c6d98b1898755633d39706af357b974a1964fb2d119e17561","id":"0cb2a90f0d28","median_sharpe_diff":-0.012,"scope":{"anlageklasse":"alle","mechanismus":"valuation"},"tests":182,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"entry_hash":"ec0b8ce7715c695dfbf4e560c2c8356560d62d2a839cc80a1f4455884b0971ce","family":"Kalender","held":0.55625,"id":"0ddc8e1f8e9c","n_significant":160.0,"signal":"CAL_PRE_FOMC","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"728aa5ae02f6c07d7289955dab8fe6d675155135a52db9fad2e74adf2d7e3f1c","family":"Krypto (Blockchain)","held":0.8518518518518519,"id":"1113f6a98367","n_significant":27.0,"signal":"P4D_OBM_SPENT_1Y_PLUS_SHARE","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"beat_benchmark":0.208,"entry_hash":"b0a8a69313afd9b0ce83eaacd0afd0bc5aef65a42f66ab461133848e6a989443","id":"13046d8d2126","median_sharpe_diff":-0.065,"scope":{"anlageklasse":"alle","mechanismus":"attention"},"tests":24,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"beat_benchmark":0.569,"entry_hash":"cd019d02844161140d0245bc094cb12add7fa5858534cfdca9c577fba4762375","id":"13c5ef99eb27","median_sharpe_diff":0.006,"scope":{"anlageklasse":"commodities","mechanismus":"supply_demand"},"tests":51,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"beat_benchmark":0.5,"entry_hash":"5c7aafa121d674b3a9bf6a677b5974130df832addddf7cea3e0ffe3b1722cf48","id":"13f64527e8b8","median_sharpe_diff":-0.002,"scope":{"anlageklasse":"equity_intl","mechanismus":"valuation"},"tests":24,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"entry_hash":"24a7c5c6eec3826f43c309657156a5ab1866b875d630ff71684ce9a516c335e1","family":"Ausland","held":0.4927536231884058,"id":"17f18e2c8c0f","n_significant":69.0,"signal":"P4D_OECD_CLI_G7","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"beat_benchmark":0.301,"entry_hash":"87907757bdf2012877098919175c681dd874bf92804e97a42b8ad82f6a8fe716","id":"1a65e0d5ee80","median_sharpe_diff":-0.056,"scope":{"anlageklasse":"alle","mechanismus":"positioning"},"tests":302,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"beat_benchmark":0.365,"entry_hash":"123196a14f79d987ca57ba9fec75d8b066c8617c3bc375aeb2b09cd44455bbc0","id":"1ebe4bcae016","median_sharpe_diff":-0.026,"scope":{"anlageklasse":"equity_us","mechanismus":"macro_timing"},"tests":148,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"entry_hash":"4f34d0615af475efd0610c6f79c3d98668a5367f9d1eb3d45a1f0190374d78b5","family":"Erwartungen/Wirtschaft","held":0.46511627906976744,"id":"1ff796d028c7","n_significant":43.0,"signal":"P4D_SURPRISE_INDEX","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"90d761c717e0eb6be3a09aeda4bee14b7b08b74e7d41ccbea7151373b128ab60","family":"Unsicherheit/Nachrichten","held":0.34782608695652173,"id":"2307689c89fe","n_significant":23.0,"signal":"P4D_GPR_COUNTRY_ESP","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"b19a3871d5d2ad8a500b94ed0d32b485a086b4b66a3e1303c0d2c33f46587aec","family":"Unsicherheit/Nachrichten","held":0.5319148936170213,"id":"245059b35ba2","n_significant":47.0,"signal":"P4D_GPR_COUNTRY_CAN","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"beat_benchmark":0.304,"entry_hash":"820c82556c2a4b0abddfbf6d272560eaa90e0bafc32ea010cd2fac90b6eaabc4","id":"245296a573fe","median_sharpe_diff":-0.045,"scope":{"anlageklasse":"alle","mechanismus":"mixed"},"tests":382,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"entry_hash":"f4315e5a3032ce70b117191e98adc510a2c0578a0d310a0a0fc361ba0f613754","family":"Ausland","held":0.5813953488372093,"id":"26231dec5bae","n_significant":43.0,"signal":"P4D_OECD_CLI_CHN","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"c0d6a0351622adcaf7c0c1748a15f7f0df8094e6fbd0caa61ffa507dbddd10c9","family":"Unsicherheit/Nachrichten","held":0.45454545454545453,"id":"26cd740af7b0","n_significant":44.0,"signal":"P4D_GPR_MONTHLY","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"beat_benchmark":0.3,"entry_hash":"b4478b0a1910d2bb1afafe5ded790c9e79c51de50c52005db624b5c07ef266e2","id":"26f10b249875","median_sharpe_diff":-0.051,"scope":{"anlageklasse":"equity_us","mechanismus":"valuation"},"tests":120,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"entry_hash":"ac2ecbdea44ba7673c60fd371c979be677212d56010dbac885bc601c619f6575","family":"Notenbanken (Ausland)","held":0.3333333333333333,"id":"2c0142c85c1a","n_significant":27.0,"signal":"P6D_SNB_FX_CHG3","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"beat_benchmark":0.389,"entry_hash":"4d3e11bacdd17c014e986405f9295ff5bccba43796baf00676a134aad59ece4b","id":"2c192582e5f0","median_sharpe_diff":-0.042,"scope":{"anlageklasse":"multi_asset","mechanismus":"price_rule"},"tests":36,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"beat_benchmark":0.17,"entry_hash":"fc916ca7766858a759df24d0393ab7fe8e88bb6e2098626b26e45530449c4f8f","id":"2c5a8dda2d55","median_sharpe_diff":-0.901,"scope":{"anlageklasse":"equity_us","mechanismus":"calendar"},"tests":53,"type":"base_rate","verdict":"Sackgasse"},{"entry_hash":"288b4d05fc4a498ab2d7505ccd354b8c96159ad702b1ce7ac4eeeaade829e103","family":"Ausland/Geldflüsse","held":0.022222222222222223,"id":"33f866c6c6a4","n_significant":225.0,"signal":"P4D_MOF_FOREIGN_JP_BONDS","type":"signal","verdict":"auffällig instabil (unter Placebo-5 %)"},{"beat_benchmark":0.467,"entry_hash":"ca87dc1e48c7c6d5798e7221fef5cac1e51367cb69387dfc38d715187a8e6827","id":"343e242cb333","median_sharpe_diff":-0.008,"scope":{"anlageklasse":"commodities","mechanismus":"positioning"},"tests":45,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"entry_hash":"77a63174e5154ddeff01f57478eba27077dde6e455845d6ea74079f9fbd81a79","family":"Geldflüsse (ETF)","held":0.4873417721518987,"id":"352f9022ef3a","n_significant":316.0,"signal":"P6D_ETF_FLOW20_LQD","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"30e93854e1603e1ed73905454b646617061368e33fe6327a27b99a36c28f8495","family":"Unsicherheit/Nachrichten","held":0.43209876543209874,"id":"36727f2c5cca","n_significant":162.0,"signal":"P4D_GPR_COUNTRY_KOR","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"3b764384421c0b7bcf39cacb9d21123ba7f7cea33b7a7b6954992f22fd13c200","family":"Ausland","held":0.9310344827586207,"id":"383e77cd6a7b","n_significant":29.0,"signal":"P4D_OECD_CLI_KOR","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"c7dca2608e8de256687fbff5a7020ecdb590f6dcacd39d1828803dcf6c94e31e","family":"Liquidität","held":0.47619047619047616,"id":"38522fbf15a5","n_significant":21.0,"signal":"P4D_DTS_TGA","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"a653e8be97a3cc5fb6fb90a7c33d95b5de9be9cf0c1f2ab6c8c3a79039b3df90","family":"Ausland","held":0.6330275229357798,"id":"38f94bb91e63","n_significant":109.0,"signal":"P4D_OECD_CLI_FRA","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"59a3ce945c4e58a4f8354f08e472d0c9f0a39f8ee16a3b717dab6fc8dd73c2f4","family":"Ausland","held":0.75,"id":"3b3d14d61612","n_significant":24.0,"signal":"P4D_OECD_CLI_AUS","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"87450fb31682b02ef13ea8ab01d4327c5e7c29e35c3706d9ffe9ae410fcf5ca1","family":"Realwirtschaft","held":0.5106382978723404,"id":"3d54196127f0","n_significant":141.0,"signal":"P4D_EIA_GASOLINE_DEMAND","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"beat_benchmark":0.763,"entry_hash":"67d9b28d3122370f20dd04f073ed12670dcba69889ffc9cc27270c6f5042ee99","id":"3e923d5650c8","median_sharpe_diff":0.083,"scope":{"anlageklasse":"commodities","mechanismus":"lead_lag"},"tests":38,"type":"base_rate","verdict":"eher tragfähig (prüfen)"},{"entry_hash":"0979c570fb90586066aea8b771972a817874cd9eaa41f6da1105f08af906a4f0","family":"Kalender","held":0.1076923076923077,"id":"40cd3191731c","n_significant":130.0,"signal":"CAL_YEAR_END","type":"signal","verdict":"auffällig instabil (unter Placebo-5 %)"},{"entry_hash":"f6bccf0ac75a78fff810b97bbab28e4b87dc113f8998c66937cff88482ca9fc7","family":"Unsicherheit/Nachrichten","held":0.36416184971098264,"id":"483687ddebe5","n_significant":173.0,"signal":"P4D_EMV_SHARE_MONETARY_POLICY","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"beat_benchmark":0.362,"entry_hash":"e42c216d8ee22ebd8387130f1929876e707bebb793274820d8ed6ccd091c81af","id":"4d1e60ecc7ae","median_sharpe_diff":-0.038,"scope":{"anlageklasse":"alle","mechanismus":"price_rule"},"tests":130,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"entry_hash":"162cebf74acf07cd9d3fa0b747a99bfac241d39820480385ed33a8169eaba419","family":"Ausland","held":0.5833333333333334,"id":"4ee3a563bd4b","n_significant":36.0,"signal":"P4D_OECD_CLI_DEU","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"6e90c033e31f5c97ec145bb762c24a8c95354872cb4d4913221c9b15db2d8181","family":"Unsicherheit/Nachrichten","held":0.45161290322580644,"id":"4f021d30a458","n_significant":31.0,"signal":"P4D_EMV_SHARE_TRADE_POLICY","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"4041fb18dc28b07ce11ee28e74a5d8993e9ba199d1ead2fde54af544aae614ab","family":"Staat/Realwirtschaft","held":0.3783783783783784,"id":"5047542dc6cc","n_significant":37.0,"signal":"P4D_DTS_WITHHELD","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"beat_benchmark":0.218,"entry_hash":"5de5ff17d792fb23d0552e3c90c097693b964ee29926227277946d0698a578b8","id":"5142e730acc4","median_sharpe_diff":-0.386,"scope":{"anlageklasse":"fx","mechanismus":"forced_flow"},"tests":261,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"entry_hash":"0a8bb72779cec6981a01e24cd8d6f7649ce9a757a4e068198e24f230caf90833","family":"Geldflüsse (ETF)","held":0.7377049180327869,"id":"5680b1f8e8c0","n_significant":61.0,"signal":"P6D_ETF_FLOW20_XLF","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"cf30b95d5f23909ee13d7cef5bf3e7a8b1c65a327851494f6e772e7a1695a374","family":"Ausland","held":0.3448275862068966,"id":"57dce1cf3c90","n_significant":29.0,"signal":"P4D_OECD_CLI_GBR","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"beat_benchmark":0.363,"entry_hash":"62415a3268ebfff2d20dc568f40830eb9ba59f3e1a54e9ef6a68a85a2df2eb18","id":"587e6e2389e8","median_sharpe_diff":-0.028,"scope":{"anlageklasse":"equity_intl","mechanismus":"mixed"},"tests":102,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"beat_benchmark":0.24,"entry_hash":"a2c76a638cfe8dd1da70bba0a7478e4dbd4ba1b9aa6930b887fdfc84ad9767ad","id":"5bbdc184162b","median_sharpe_diff":-0.34,"scope":{"anlageklasse":"alle","mechanismus":"forced_flow"},"tests":288,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"beat_benchmark":0.364,"entry_hash":"98ba063684ff49fc47f2b658539856ca5b81314ec8e664d6b28ce635c58bc1bc","id":"5ed0cd340be6","median_sharpe_diff":-0.046,"scope":{"anlageklasse":"equity_intl","mechanismus":"liquidity_credit"},"tests":77,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"entry_hash":"ac14c182ab5329fb6493f07bb45fc0de9ae89a2ddad97387c304809df91b6e97","family":"Staat","held":0.7142857142857143,"id":"61249eec1ec8","n_significant":28.0,"signal":"P4D_AUCTION_HI_MINUS_MED","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"0b38649d409ad3b8125d758714a3be9bf2f77fc783bcfd979c641a2a0331a984","family":"Notenbanken (Ausland)","held":0.12037037037037036,"id":"630a31c09c87","n_significant":108.0,"signal":"P6D_SNB_SIGHT_CHG4","type":"signal","verdict":"auffällig instabil (unter Placebo-5 %)"},{"beat_benchmark":0.367,"entry_hash":"34211212b433c3ba08e94c126b42d6c83ea47958517c7bc521c56ec7d7a3210d","id":"636920b86c0d","median_sharpe_diff":-0.044,"scope":{"anlageklasse":"equity_us","mechanismus":"behavioural"},"tests":49,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"entry_hash":"d1c30c73873853295753f5e642095494e510a2318dae965a8a0b27f68a83b81f","family":"Unsicherheit/Nachrichten","held":0.9230769230769231,"id":"63bece7170a7","n_significant":26.0,"signal":"P4D_GPR_COUNTRY_UKR","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"beat_benchmark":0.433,"entry_hash":"c47bfeb135fb25da4ed19de4821da7187fdeddd55de02201bb7a87d25751f637","id":"6430fa842734","median_sharpe_diff":-0.001,"scope":{"anlageklasse":"fx","mechanismus":"macro_timing"},"tests":67,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"entry_hash":"9b71fc16fab6f418e46f33a9a395f3cd1e68d26f09527427c3f78c659a72daf6","family":"Erwartungen","held":0.09433962264150944,"id":"6436da556fd7","n_significant":106.0,"signal":"P4D_PHILLY_FUTURE","type":"signal","verdict":"auffällig instabil (unter Placebo-5 %)"},{"beat_benchmark":0.552,"entry_hash":"2d309837dc70fb1ae0805b57e090fa22b105b64f1da8c52c3d9f1170e2a6fdb4","id":"65476f3f13c3","median_sharpe_diff":0.011,"scope":{"anlageklasse":"equity_intl","mechanismus":"behavioural"},"tests":29,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"entry_hash":"f32fbfdd480c34e87ca91f6d2d51fbb879daac84b0543bc351bbd5b6e42dc0cc","family":"Positionierung","held":0.4838709677419355,"id":"6683ec420264","n_significant":31.0,"signal":"P4D_FINRA_MARGIN_DEBT","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"beat_benchmark":0.435,"entry_hash":"2fe8cc2f7c1d07725af4c2b19cec78c4757dd63a5d632e68a798719667f0ce9a","id":"66ea85afdef5","median_sharpe_diff":0.0,"scope":{"anlageklasse":"fx","mechanismus":"risk_premium"},"tests":23,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"beat_benchmark":0.184,"entry_hash":"3a962c382446156a07354095c69a2fa4c2a448e090e90452e5aa2ebe860bd793","id":"679debcae084","median_sharpe_diff":-0.501,"scope":{"frequenz":"intraday"},"tests":347,"type":"base_rate","verdict":"Sackgasse"},{"entry_hash":"1de6be5f9f9efad37fd65078ce64c82888e064e6bd4a3ed8af778169dcf05e18","family":"Positionierung (Privatanleger)","held":0.9305555555555556,"id":"68dcb573da64","n_significant":144.0,"signal":"P4D_LEVETF_BEAR_SHARE_SPX","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"503b5e3ada4bc616093079e8a2991e15b1df4ebb4beb78fe2ecae8eb12d3be54","family":"Krypto (Blockchain)","held":0.7714285714285715,"id":"69cdccb8376a","n_significant":35.0,"signal":"P6D_CM_BTC_EX_SHARE","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"5344181f3f2ea8a1c8b82fa7f0a229e22a6ccf49478fa109cef9e7d11e4852a1","family":"Unsicherheit/Nachrichten","held":0.05217391304347826,"id":"6c5e0ab25aa1","n_significant":115.0,"signal":"P4D_GPR_COUNTRY_SAU","type":"signal","verdict":"auffällig instabil (unter Placebo-5 %)"},{"entry_hash":"7d6ee2a31e08afcc0274c13ff36dc53a0d76042ce6d3888b27f0ca156e932f03","family":"Ausland","held":0.46218487394957986,"id":"6f073bf2eaaf","n_significant":238.0,"signal":"P4D_OECD_CLI_ITA","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"14e9b73f8111c7570d7fc46265604f16ba0c9c7375b8d9e7b06bb5ad63a3af0b","family":"Geldflüsse (ETF)","held":0.48484848484848486,"id":"768972c896a4","n_significant":66.0,"signal":"P6D_ETF_FLOW20_SPY","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"beat_benchmark":0.273,"entry_hash":"bea33af0ea47e498f6722323294f29e6aae22bfc349b09ba1039a7c81dca2927","id":"79ded271b5a7","median_sharpe_diff":-0.058,"scope":{"anlageklasse":"equity_single","mechanismus":"positioning"},"tests":22,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"entry_hash":"953b99af1e79451e253b05009b61e48b4ef4686241611ed1e154d8d25d1a16a5","family":"Unsicherheit/Nachrichten","held":0.5666666666666667,"id":"79f9a937cab5","n_significant":30.0,"signal":"P4D_GPR_DAILY_ACT","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"beat_benchmark":0.176,"entry_hash":"cd3ffabe40ab97522df8eaed7b2f8aa9f86b867e99fb2ca700229da9e9e77a49","id":"7bfa8e50eb11","median_sharpe_diff":-0.096,"scope":{"anlageklasse":"equity_us","mechanismus":"positioning"},"tests":142,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"entry_hash":"f0e15f73d7a9fd404a913ad2477d45880d45c3db7f5cc4c43a1a05a9af082051","family":"Ausland","held":0.6538461538461539,"id":"7e7cbbf6efec","n_significant":52.0,"signal":"P4D_OECD_CLI_IND","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"9ef415df40e2ed64387b20c89ec712bb405e5d7e755eea52205ab9101d72bdf0","family":"Krypto (Blockchain)","held":0.92,"id":"7f87bbd0703b","n_significant":25.0,"signal":"P4D_OBM_LIVELINESS","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"beat_benchmark":0.318,"entry_hash":"bd8e832ae3968fa2ba46a0f600ae4d1dc82800daf88d789dbafefb034953969d","id":"802c01013ef7","median_sharpe_diff":-0.055,"scope":{"anlageklasse":"equity_us","mechanismus":"supply_demand"},"tests":66,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"beat_benchmark":0.591,"entry_hash":"90043e36c95101e2e33f137054241430ffa2930cd5f0fefd9c315377e432ab07","id":"848a269540cf","median_sharpe_diff":0.006,"scope":{"anlageklasse":"equity_single","mechanismus":"other"},"tests":22,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"entry_hash":"ed73cb97f26172d21b2d4c73c77dcb73bdacb48320bda6bec98d82ded3832158","family":"Unsicherheit/Nachrichten","held":0.3191489361702128,"id":"854e43cadabb","n_significant":47.0,"signal":"P4D_GPR_DAILY","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"beat_benchmark":0.0,"entry_hash":"2e429398b0626001f8668b712c84bca8ab869e8195c6443b5861c063297b34f6","id":"88b5c2dca0fb","median_sharpe_diff":-1.471,"scope":{"anlageklasse":"equity_single","mechanismus":"calendar"},"tests":34,"type":"base_rate","verdict":"Sackgasse"},{"beat_benchmark":0.249,"entry_hash":"3a10c5943aaa0a0dff3a4529b1093f5883cbe9d9fd1db7dbdd3995a0b75f36d8","id":"88cf8e5359f1","median_sharpe_diff":-0.058,"scope":{"anlageklasse":"equity_us","mechanismus":"mixed"},"tests":237,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"entry_hash":"e860492a4e4b179e5d2f94617e5156c131e6b75c2716e56c7a8e1af9ba8e88fa","family":"Geldflüsse (ETF)","held":0.43478260869565216,"id":"8c23e4efed40","n_significant":23.0,"signal":"P6D_ETF_FLOW20_EEM","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"777fb05f485ecf3a16195db7439b3c9f070f2065868d7da67f104ad632a706d2","family":"Unsicherheit/Nachrichten","held":0.6107660455486542,"id":"8f62ae3509e7","n_significant":483.0,"signal":"P4D_GPR_COUNTRY_IND","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"beat_benchmark":0.475,"entry_hash":"9a00dd2ca910898c3950b2d3acd8ac15971999e1e4f0d458ee26fbe45a2c89e4","id":"91ba3f54ec12","median_sharpe_diff":-0.016,"scope":{"anlageklasse":"equity_intl","mechanismus":"macro_timing"},"tests":61,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"entry_hash":"4d2f99cd5a9ad077bd0e2b60e0b71fe285465dafe53879aeee62543eae8a361b","family":"Unsicherheit/Nachrichten","held":0.25,"id":"9347b9d6310c","n_significant":20.0,"signal":"P4D_GPR_COUNTRY_DEU","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"beat_benchmark":0.257,"entry_hash":"424792a92946eb086c491d3655cf6b3162cd745921e8fcfb063c7a11568b2125","id":"970686c70838","median_sharpe_diff":-0.168,"scope":{"anlageklasse":"alle","mechanismus":"lead_lag"},"tests":412,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"entry_hash":"11dddcafff0c51b108136992819363fbcf2d8d608ae743208f6645e83e4567c1","family":"Realwirtschaft (Fracht)","held":0.13725490196078433,"id":"981e2cb55470","n_significant":51.0,"signal":"P6D_CASS_EXP_YOY","type":"signal","verdict":"auffällig instabil (unter Placebo-5 %)"},{"entry_hash":"2498e5fa4fa46245efb055d9c1fba37606f3c750c1b8b35913f0963637b79cfe","family":"Realwirtschaft/Ausland","held":0.20833333333333334,"id":"98a1d64916a2","n_significant":48.0,"signal":"P4D_KOREA_EXPORTS_MONTHLY","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"981351caca6dcf2d22d569e71113d5b4e1901fa5cd6e347f991fc8673fee56ba","family":"Positionierung (Privatanleger)","held":0.8932038834951457,"id":"99854b01ec91","n_significant":103.0,"signal":"P4D_LEVETF_BEAR_SHARE_NDX","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"beat_benchmark":0.406,"entry_hash":"72991ffcc36f98a7ee45e0ad7d6784e9a69e61f4098008c78acc3770a12637a9","id":"9d0ce2b25671","median_sharpe_diff":-0.037,"scope":{"anlageklasse":"alle","mechanismus":"other"},"tests":128,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"entry_hash":"ddf39f18a5ff40ea7429abe570f0d6ea645e2711af0df124577c9616b2c8d6c7","family":"Unsicherheit/Nachrichten","held":0.7567567567567568,"id":"9e0348ab667b","n_significant":37.0,"signal":"P4D_GPR_COUNTRY_BRA","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"5184c9847c414a528963e6c6470af1ee498bfc9f239dad8c1a13e58079fcd6b1","family":"Erwartungen","held":0.9172413793103448,"id":"9f5b3b2883fd","n_significant":145.0,"signal":"P4D_PHILLY_GAP","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"91f7a82fcd8b5b055b68f9b9825444808022487377b4c966e59480292a186a4a","family":"Positionierung","held":0.40425531914893614,"id":"a13eec3126f6","n_significant":47.0,"signal":"P4D_FINRA_MARGIN_NET","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"02991ade15b7d8708c71b2e8fb2bb3da75ba5e989f54c6fd2be6e101c71086cd","family":"Realwirtschaft","held":0.5277777777777778,"id":"a29f8c865e57","n_significant":36.0,"signal":"P4D_EIA_CRUDE_STOCKS_FIRST","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"cdec7dcf131dd1232b6518daecd4cabde5385f89134b76ef1ed57ef6eaa2fcc1","family":"Geldflüsse (ETF)","held":0.6521739130434783,"id":"a64ac4b6ae07","n_significant":23.0,"signal":"P6D_ETF_FLOW20_XLI","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"beat_benchmark":0.376,"entry_hash":"2231a699089b40044bc903eb1a8e897a46e925d2e78343246a8f2d4312520545","id":"a723070c4213","median_sharpe_diff":-0.069,"scope":{"anlageklasse":"equity_us","mechanismus":"other"},"tests":85,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"entry_hash":"bbae3071f53bc15443f1d09ab2f1dee012fdcbac5c6b3b0ff6e9ad8b54780ba8","family":"Unsicherheit/Nachrichten","held":0.42857142857142855,"id":"a99b486c8361","n_significant":28.0,"signal":"P4D_GPR_COUNTRY_MEX","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"beat_benchmark":0.783,"entry_hash":"a8a0c898f4ef425f53f0ad86e40e83b35e16f49f0048889768361784a84abfb8","id":"b007ee2ce325","median_sharpe_diff":0.038,"scope":{"anlageklasse":"fx","mechanismus":"valuation"},"tests":23,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"entry_hash":"4a350dd64726222d11738e7e8cc70c0a9006ccc0b5348db692e124b75570c903","family":"Unsicherheit/Nachrichten","held":0.6666666666666666,"id":"b16047c8db6e","n_significant":21.0,"signal":"P4D_EMV_OVERALL","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"beat_benchmark":0.148,"entry_hash":"de00e5db63461783cc25cd676aba6bab0c05a114923ad6ff0e09d9cda50ed051","id":"b38862b3e25e","median_sharpe_diff":-0.14,"scope":{"anlageklasse":"multi_asset","mechanismus":"mixed"},"tests":27,"type":"base_rate","verdict":"Sackgasse"},{"entry_hash":"b7318c3643d134745e20e1f92fd71828855fbecbaae7f13747e8f50dbdfaa44a","family":"Geldflüsse (ETF)","held":0.4444444444444444,"id":"b398f85fd8b4","n_significant":90.0,"signal":"P6D_ETF_FLOW20_XLP","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"beat_benchmark":0.283,"entry_hash":"8752040a6671fb274bec37ed23b03a2a1d98032caab4ed95f7c5512c10ae2c58","id":"b55487301719","median_sharpe_diff":-0.05,"scope":{"anlageklasse":"alle","mechanismus":"liquidity_credit"},"tests":258,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"beat_benchmark":0.159,"entry_hash":"e8befdba9db8ca04db989e71a80837134a76c2cbb405c9296a4e805756e578a4","id":"b8a9445cf538","median_sharpe_diff":-0.926,"scope":{"anlageklasse":"alle","mechanismus":"calendar"},"tests":126,"type":"base_rate","verdict":"Sackgasse"},{"entry_hash":"ecd554cde770bbc9bc5b4280c70668985830539d25062c3d2083e5dcf3aa1543","family":"Geldflüsse (ETF)","held":0.25,"id":"bb6c31e0178f","n_significant":20.0,"signal":"P6D_ETF_FLOW20_IWM","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"beat_benchmark":0.346,"entry_hash":"63e6c2dbe87ad72fe9e6ef97e74ce59524cd58a68703d40e794e8fe2ebdc884e","id":"bb89680e149d","median_sharpe_diff":-0.039,"scope":{"anlageklasse":"equity_us","mechanismus":"price_rule"},"tests":78,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"entry_hash":"06ff7dae8094108fa315020268e1930f2d4cac9e9af86e77e6a90b4afbf36181","family":"Ausland/Geldflüsse","held":0.5714285714285714,"id":"c19540038dc7","n_significant":21.0,"signal":"P4D_H41_CUSTODY","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"beat_benchmark":0.462,"entry_hash":"7865e9c8e490c4ed8824bb9d9826ec174116e5810e09b53697e201a7fc517522","id":"c282d8722ecf","median_sharpe_diff":0.0,"scope":{"anlageklasse":"alle","mechanismus":"risk_premium"},"tests":26,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"entry_hash":"f8b8daece78429451a3ba23d23bc49eb7a174c951e636c6d4de527855411b5fb","family":"Behörden/Firmen","held":0.7450980392156863,"id":"c2a2e24a8314","n_significant":51.0,"signal":"P4D_SEC8K_COUNT","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"9a9ecdcdaa21dc0a0c14873a64f9323c98ed28378c24f6af4a2ec316b04acb29","family":"Unsicherheit/Nachrichten","held":0.8157894736842105,"id":"c35012763a53","n_significant":38.0,"signal":"P4D_GPR_COUNTRY_FRA","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"65c8c31424a24ff071d86a86b3a5dafc8a4ca100f8af877f775d40e54286ab46","family":"Unsicherheit/Nachrichten","held":0.7,"id":"c3b2dfb57553","n_significant":30.0,"signal":"P4D_GPR_COUNTRY_RUS","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"33c56c0bd49b7d27cd17f8a716b3143b7a35abffde959f7f503c603711073ffd","family":"Ausland/Geldflüsse","held":0.0,"id":"c3cfdae4a6f5","n_significant":23.0,"signal":"P4D_MOF_JP_FOREIGN_EQUITY","type":"signal","verdict":"auffällig instabil (unter Placebo-5 %)"},{"entry_hash":"15d5491468fe801ab82c03655bac4f56c7e8475a8ba69bb4d8be9bf8d7c77caf","family":"Ausland","held":0.6049382716049383,"id":"c69fdcbbd6d2","n_significant":81.0,"signal":"P4D_OECD_CLI_A5M","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"beat_benchmark":0.625,"entry_hash":"ee26957bc6a3cf396bacc77cd893e5798863877ada64ded272315ab20ad8e27b","id":"c89ce51c2b5d","median_sharpe_diff":0.039,"scope":{"anlageklasse":"fx","mechanismus":"positioning"},"tests":24,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"beat_benchmark":0.441,"entry_hash":"ed60684fe0b9c921f26d2575b18d5dd5abd07d1e6eae27b640a29941ceeabf97","id":"caa0f2e74657","median_sharpe_diff":-0.021,"scope":{"anlageklasse":"alle","mechanismus":"supply_demand"},"tests":161,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"entry_hash":"6d83d3d79f2829c18810190e14be957f17c0b6afa54a88035e0003ee50df8529","family":"Behörden/Firmen","held":0.4636363636363636,"id":"cbda69448a65","n_significant":110.0,"signal":"P4D_SEC8K_ITEM_4_02","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"beat_benchmark":0.303,"entry_hash":"5e6b06ed22ed33856aa8dafc87f79496edb97953d2937cd2f175250b8407e09d","id":"d226867afc55","median_sharpe_diff":-0.095,"scope":{"frequenz":"weekly"},"tests":33,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"entry_hash":"681366b4dc0123cc5add1b26653a39970c330b96a4b7d1ad2aa8ccc2cc405df9","family":"Ausland/Geldflüsse","held":0.06976744186046512,"id":"d2c79aab6c2d","n_significant":43.0,"signal":"P4D_MOF_JP_FOREIGN_BONDS","type":"signal","verdict":"auffällig instabil (unter Placebo-5 %)"},{"beat_benchmark":0.067,"entry_hash":"56894b270e64d2970d0f50542d34b44573ea510671f9d490955d57c1853399f5","id":"d71afb18ca52","median_sharpe_diff":-0.207,"scope":{"anlageklasse":"equity_intl","mechanismus":"lead_lag"},"tests":30,"type":"base_rate","verdict":"Sackgasse"},{"entry_hash":"b054e95eeda1b57b78cf78eabccf56ebc6b6483e00fc93227468f13e8620fffd","family":"Ausland","held":0.42857142857142855,"id":"da434565762a","n_significant":21.0,"signal":"P4D_OECD_CLI_BRA","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"4081ba7c119b2b51e297e3ce3c1defab40ca1292d78495bab070e55573b46737","family":"Unsicherheit/Nachrichten","held":0.7297297297297297,"id":"da6895133876","n_significant":37.0,"signal":"P4D_GPR_COUNTRY_TWN","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"beat_benchmark":0.567,"entry_hash":"673cda03ad41397367e26ef3c532c9e55f19df01fcd16ae3bfe192bbf8948cd2","id":"dbddff29b441","median_sharpe_diff":0.044,"scope":{"anlageklasse":"bonds_govt","mechanismus":"lead_lag"},"tests":30,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"entry_hash":"539339a4ad7022fb15a10fe810e461c9e0087a3f2259cd1aa6a454d33252e811","family":"Behörden/Firmen","held":0.12863070539419086,"id":"dcf36cc368ad","n_significant":241.0,"signal":"P4D_SEC8K_ITEM_2_05","type":"signal","verdict":"auffällig instabil (unter Placebo-5 %)"},{"entry_hash":"76026e3f95a2656ae29b7fbcb1d8f3ddab344d94a726868497c1604b98092960","family":"Unsicherheit/Nachrichten","held":0.6862745098039216,"id":"e33e4764ed07","n_significant":51.0,"signal":"P4D_GPR_COUNTRY_USA","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"beat_benchmark":0.322,"entry_hash":"6a0a8f5584b93a7de3038912f1e00f7c298c64f4f576db992942b507f97bab5f","id":"e640f2242d6c","median_sharpe_diff":-0.056,"scope":{"frequenz":"monthly"},"tests":1790,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"beat_benchmark":0.232,"entry_hash":"77e5141d66e5a97685c94feadfa5a80cd24c0be1b1844b7ad164ec4a4501cbb2","id":"e691dbaf657f","median_sharpe_diff":-0.06,"scope":{"anlageklasse":"equity_us","mechanismus":"liquidity_credit"},"tests":155,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"beat_benchmark":0.166,"entry_hash":"a43227e335f2416a43c386464fda9e80634a45d4df9b8352ee88adfe0813b601","id":"e6f52498818f","median_sharpe_diff":-0.232,"scope":{"anlageklasse":"equity_us","mechanismus":"lead_lag"},"tests":289,"type":"base_rate","verdict":"Sackgasse"},{"entry_hash":"3a7d7e42388a9b1281b81f2fd3684ee2f4de1c098eea9316e84319d1ce1663f4","family":"Unsicherheit/Nachrichten","held":0.5714285714285714,"id":"e83eab1c7eaf","n_significant":21.0,"signal":"P4D_GPR_COUNTRY_ZAF","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"7733f08dcd4defa93a6a752e4e31d83f8c0d89ff3e759efc45567c192d85ebcc","family":"Unsicherheit/Nachrichten","held":0.7027027027027027,"id":"e88c2b9b0bcc","n_significant":148.0,"signal":"P4D_GPR_COUNTRY_JPN","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"8ce100c79a3197510ad3eddb08ade7ace6d67bc7412eb14273daf68e03a4dfcd","family":"Unsicherheit/Nachrichten","held":0.6666666666666666,"id":"ec36ee199130","n_significant":36.0,"signal":"P4D_GPR_COUNTRY_ISR","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"ad53547c23935f94ad190f8efacf66750b31c5b8c21075b3e63775b527ce9522","family":"Unsicherheit/Nachrichten","held":0.821917808219178,"id":"f0cbe2ab5394","n_significant":146.0,"signal":"P4D_EMV_SHARE_INFLATION","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"entry_hash":"8d5d6a85bf51654904b38ee69899bd5fb073c7ba608b1cd235177a7e281eb027","family":"Unsicherheit/Nachrichten","held":0.36,"id":"f25701fa138d","n_significant":25.0,"signal":"P4D_GPR_COUNTRY_GBR","type":"signal","verdict":"nicht von Placebo unterscheidbar"},{"beat_benchmark":0.396,"entry_hash":"bf02fd136616399ebd0e22ed2f4aacb584341a4b38f87c3d7463735fd2283e21","id":"f373cbcd4131","median_sharpe_diff":-0.022,"scope":{"frequenz":"rare(<=3 trades/yr)"},"tests":628,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"beat_benchmark":0.413,"entry_hash":"808d3698f4e8c9bc2016b9e05fe66dcc7d8533d679ef657e4c281e24a89990e3","id":"f6d4ca6d1df3","median_sharpe_diff":-0.016,"scope":{"anlageklasse":"alle","mechanismus":"macro_timing"},"tests":315,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"beat_benchmark":0.315,"entry_hash":"d81383dad4a7ab7dfb47550943880be99b7204b4d3d66735c2d1bb5e53393612","id":"f8b4d31b1b08","median_sharpe_diff":-0.039,"scope":{"anlageklasse":"equity_intl","mechanismus":"positioning"},"tests":54,"type":"base_rate","verdict":"überwiegend kein Vorteil"},{"beat_benchmark":0.464,"entry_hash":"7c25329d9488e227dd9587566753fce0f498f84f020064b11af45cc25df046c6","id":"fb9941929b23","median_sharpe_diff":-0.03,"scope":{"anlageklasse":"equity_intl","mechanismus":"supply_demand"},"tests":28,"type":"base_rate","verdict":"überwiegend kein Vorteil"}],"n_entries":124,"source":"register_v0 / befunde_v0"}